Clinical Trials Browser

Phase 3 × Nasopharyngeal Neoplasms × camrelizumab × Clear all

NCT03427827 2024-04-09

DIPPER

Phase 3 Active not recruiting

Nasopharyngeal Neoplasms

NCT04453826 2020-09-28

Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma

Phase 3 Recruiting

Nasopharyngeal Neoplasms